Phase 1, Dose Escalation Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer.
Phase of Trial: Phase I
Latest Information Update: 10 Apr 2013
At a glance
- Drugs Carboplatin; Figitumumab; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Biomarker
- Sponsors Pfizer
- 10 Jun 2017 Biomarkers information updated
- 15 Jul 2009 Actual patient number (19) added as reported by ClinicalTrials.gov.
- 15 Jul 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.